Zobrazeno 1 - 10 of 70 pro vyhledávání: '"Kaisa M Mäki-Petäjä"'
1
Akademický článek
Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study
Autor: Divya Mohan, Carmel M McEniery, John R Cockcroft, William MacNee, Jonathan Fuld, Marie Fisk, Joseph Cheriyan, Ruth Tal-Singer, Ian B Wilkinson, Jilles M Fermont, Hana Müllerova, Angela M Wood, Charlotte E Bolton, Kaisa M Mäki-Petäjä, Ali B Al-Hadithi
Publikováno v: BMJ Open, Vol 10, Iss 12 (2020)
Objectives Although cardiovascular disease (CVD) is a common comorbidity associated with chronic obstructive pulmonary disease (COPD), it is unknown how to improve prediction of cardiovascular (CV) risk in individuals with COPD. Traditional CV risk s
Externí odkaz: https://doaj.org/article/28be3a2dbdbf48adb16eaad8e2b66add
Zobrazit plný text záznamu
2
Akademický článek
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial.
Autor: Marie Fisk, Joseph Cheriyan, Divya Mohan, Julia Forman, Kaisa M Mäki-Petäjä, Carmel M McEniery, Jonathan Fuld, James H F Rudd, Nicholas S Hopkinson, David A Lomas, John R Cockcroft, Ruth Tal-Singer, Michael I Polkey, Ian B Wilkinson
Publikováno v: PLoS ONE, Vol 13, Iss 3, p e0194197 (2018)
BackgroundCardiovascular disease is a major cause of morbidity and mortality in COPD patients. Systemic inflammation associated with COPD, is often hypothesised as a causal factor. p38 mitogen-activated protein kinases play a key role in the inflamma
Externí odkaz: https://doaj.org/article/b8081b2e4dcf46128fb118fce2ecb2ca
Zobrazit plný text záznamu
3
Akademický článek
Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial.
Autor: Parag R Gajendragadkar, Annette Hubsch, Kaisa M Mäki-Petäjä, Martin Serg, Ian B Wilkinson, Joseph Cheriyan
Publikováno v: PLoS ONE, Vol 9, Iss 6, p e99070 (2014)
AIMS:The mechanisms by which a 'Mediterranean diet' reduces cardiovascular disease (CVD) burden remain poorly understood. Lycopene is a potent antioxidant found in such diets with evidence suggesting beneficial effects. We wished to investigate the e
Externí odkaz: https://doaj.org/article/251aab55edbc4be78c8836ae9f699b27
Zobrazit plný text záznamu
4
Quantitative 18F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD
Autor: Laurence Vass, Divya Mohan, Ruth Tal-Singer, Kaisa M. Mäki-Petäjä, Julia R. Forman, Jonathan Fuld, Marie Fisk, John R. Cockcroft, Anand Devaraj, Nicholas S Hopkinson, Ian B. Wilkinson, Carmel M. McEniery, Joseph Cheriyan, Adelola Oseni, Michael I. Polkey, David A. Lomas
Publikováno v: ERJ Open Research, Vol 7, Iss 3 (2021)
ERJ Open Research
article-version (VoR) Version of Record
Rationale COPD and smoking are characterised by pulmonary inflammation. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) imaging may improve knowledge of pulmonary inflammation in COPD patients and aid early develo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9979acff13ce7a880f113d1f71c6a6a4
https://doi.org/10.1183/23120541.00699-2020
Zobrazit plný text záznamu
5
Akademický článek
Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis
Autor: Kaisa M. Mäki‐Petäjä, Lisa Day, Joseph Cheriyan, Frances C. Hall, Andrew J. K. Östör, Nicholas Shenker, Ian B. Wilkinson
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 2 (2016)
BackgroundRheumatoid arthritis is a systemic inflammatory condition associated with increased cardiovascular risk that may be due to underlying endothelial dysfunction and subsequent aortic stiffening. We hypothesized that supplementation with tetrah
Externí odkaz: https://doaj.org/article/a63a8cba920e40c0936f74d50ed32d10
Zobrazit plný text záznamu
6
Uses of Arterial Stiffness in Clinical Practice
Autor: Gary F. Mitchell, Ian B. Wilkinson, Kaisa M. Mäki-Petäjä
Publikováno v: Arterioscler Thromb Vasc Biol
As far back as the ancient Egyptians and Greeks, physicians have observed and interpreted the arterial pulse to diagnose disease. In the last 20 years, advances in modern engineering have rendered quantitative pulse wave analysis widely available, re
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd58400e62753ca23f5df402e7d3bc67
https://doi.org/10.1161/atvbaha.120.313130
Zobrazit plný text záznamu
8
Evaluation of inert gas rebreathing for determination of cardiac output: influence of age, gender and body size
Autor: Alex Cocks, Kaido Paapstel, Carmel M. McEniery, Ian B. Wilkinson, Sunita, Jessica Middlemiss, Kaisa M. Mäki-Petäjä
Publikováno v: Hypertension Research
The aim of this study was to evaluate an inert gas rebreathing method (Innocor) for measurement of cardiac output and related haemodynamic variables and to provide robust normative data describing the influence of age, gender and body size on these v
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78bea59bf11b90d851d7ad8d678bd584
https://doi.org/10.1038/s41440-018-0179-1
Zobrazit plný text záznamu
9
Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension – The Hypaz Trial
Autor: Ian B. Wilkinson, Carola-Bibiane Schönlieb, Sara Santos Franco, Yoeri E. Boink, Christoph Brune, Annette Hubsch, Adam McGeoch, Lucy Yang, Fraz Mir, Simon Bond, Carmel M. McEniery, Nicola Ramenatte, Duncan I. Jodrell, Kaisa M. Mäki-Petäjä, Gayathri Anandappa, Joseph Cheriyan, Paul A R Meyer, Parag R Gajendragadkar
Publikováno v: Hypertension
Hypertension, 77(5), 1591-1599. Lippincot, Williams & Wilkins
Drugs targeting the VEGF (vascular endothelial growth factor) signaling pathway are approved for several malignancies. Unfortunately, VEGF inhibitors lead to hypertension in 30% to 80% patients. Reduced nitric oxide synthase activity, microvascular r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755d8a0ee36ffb6c589f28eef9112952
https://europepmc.org/articles/PMC7610566/
Zobrazit plný text záznamu
10
Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study
Autor: Charlotte E. Bolton, Carmel M. McEniery, Angela M. Wood, Jonathan Fuld, Ian B. Wilkinson, Hana Müllerová, Divya Mohan, Joseph Cheriyan, Ali B.A.K. Al-Hadithi, Ruth Tal-Singer, Michael I. Polkey, William MacNee, Jilles M Fermont, John R. Cockcroft, Kaisa M. Mäki-Petäjä, Marie Fisk
Publikováno v: BMJ Open, Vol 10, Iss 12 (2020)
BMJ Open
Funder: National Institute for Health Research; FundRef: http://dx.doi.org/10.13039/501100000272
Funder: Health Data Research UK
Funder: NIHR Cambridge Comprehensive Biomedical Research Centre
Funder: NIHR Nottingham BRC respiratory th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::608a69f64f25e65aef09779b7fb6d86f
https://bmjopen.bmj.com/content/10/12/e038360.full
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje